$8.70
0.020.23%
At close: -
$8.70
0.001500.02%
After Hours: Dec 20, 7:29 PM EDT
Comments
Loading...
Novavax (NASDAQ:NVAX) Stock Quotes, Forecast and News Summary
Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Novavax (NVAX) stock?
You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.
Who are Novavax (NVAX) competitors?
Other companies in Novavax’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Syndax Pharmaceuticals (NASDAQ:SNDX), Arcutis Biotherapeutics (NASDAQ:ARQT), Day One Biopharmaceutical (NASDAQ:DAWN) and CareDx (NASDAQ:CDNA).
What is the forecast, or price target, for Novavax (NVAX) stock?
Novavax has a consensus price target of $48.13.
What is the current price for Novavax (NVAX)?
The stock price for Novavax (NASDAQ: NVAX) is $8.7015 last updated December 20, 2024 at 7:29 PM EST.
Does Novavax (NVAX) pay a dividend?
There are no upcoming dividends for Novavax.
When is Novavax (NASDAQ:NVAX) reporting earnings?
Novavax’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Novavax (NVAX) going to split?
There is no upcoming split for Novavax.
What sector and industry does Novavax (NVAX) operate in?
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.